A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Renaissance Technologies LLC holds 14,200 shares of DRTS stock, worth $31,666. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,200
Holding current value
$31,666
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.01 - $2.55 $28,541 - $36,210
14,200 New
14,200 $33,000
Q1 2024

May 13, 2024

SELL
$2.84 - $3.35 $28,116 - $33,165
-9,900 Reduced 40.24%
14,700 $43,000
Q4 2023

Feb 13, 2024

BUY
$2.75 - $3.89 $67,650 - $95,694
24,600 New
24,600 $74,000
Q3 2022

Nov 14, 2022

BUY
$0.65 - $11.0 $12,360 - $209,176
19,016 New
19,016 $111,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $154M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.